000			01854 a2200457 4500
005			20250513215622.0
264		0	_c20001011
008			200010s 0 0 eng d
022			_a0893-133X
024	7		_a10.1016/S0893-133X(00)00101-9 _2doi
040			_aNLM _beng _cNLM
100	1		_aSwartz, B E
245	0	0	_aThe effects of an alpha-2 adrenergic agonist, guanfacine, on rCBF in human cortex in normal controls and subjects with focal epilepsy. _h[electronic resource]
260			_bNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology _cSep 2000
300			_a263-75 p. _bdigital
500			_aPublication Type: Clinical Trial; Journal Article; Research Support, U.S. Gov't, Non-P.H.S.
650	0	4	_aAdrenergic alpha-2 Receptor Agonists
650	0	4	_aAdrenergic alpha-Agonists _xpharmacology
650	0	4	_aAdult
650	0	4	_aBlood Pressure _xdrug effects
650	0	4	_aCerebral Cortex _xblood supply
650	0	4	_aCerebrovascular Circulation _xdrug effects
650	0	4	_aEpilepsies, Partial _xdiagnostic imaging
650	0	4	_aEpilepsy, Temporal Lobe _xdiagnostic imaging
650	0	4	_aFemale
650	0	4	_aFluorodeoxyglucose F18
650	0	4	_aGuanfacine _xpharmacology
650	0	4	_aHumans
650	0	4	_aMale
650	0	4	_aMemory, Short-Term _xdrug effects
650	0	4	_aMiddle Aged
650	0	4	_aPsychomotor Performance _xdrug effects
650	0	4	_aRadiopharmaceuticals
650	0	4	_aTomography, Emission-Computed
700	1		_aKovalik, E
700	1		_aThomas, K
700	1		_aTorgersen, D
700	1		_aMandelkern, M A
773	0		_tNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology _gvol. 23 _gno. 3 _gp. 263-75
856	4	0	_uhttps://doi.org/10.1016/S0893-133X(00)00101-9 _zAvailable from publisher's website
999			_c10891659 _d10891659